Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evotec Se (OP: EVOTF ) 6.773 UNCHANGED Last Price Updated: 12:15 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Evotec Se Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb January 07, 2024 Via ACCESSWIRE Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories July 05, 2023 Reuters Via Benzinga Evotec Secures US Government Contract For Orthopoxvirus Antibody July 05, 2023 The U.S. Via Benzinga Adapsyn Bioscience Inks Collaboration Pact With Evotec September 21, 2022 Via Benzinga The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate July 06, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Evotec Enters a Drug Discovery Collaboration with Janssen June 14, 2022 HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen... From Evotec SE Via AccessWire Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology May 19, 2022 HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global... From Evotec AG Via AccessWire Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures April 12, 2022 - STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE - DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES - SUBSTANTIALLY... From Evotec AG Via AccessWire Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb April 08, 2022 - THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB - EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A... From Evotec AG Via AccessWire Why Are Evotec Shares Trading Lower On Friday? February 04, 2022 Bayer AG (OTC: BAYRY) has Via Benzinga Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic January 03, 2022 - EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT... From Evotec AG Via AccessWire Exposures COVID-19 Germany Based Evotec Sets Terms For $576M US IPO October 27, 2021 German biotech Evotec SE (OTC: EVTCY) plans to raise $576 million by offering 22 million ADSs at $26.16. At the proposed price, Evotec would command a market value of $... Via Benzinga Pasithea, Evotec Ink Drug Development Pact October 11, 2021 Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research... Via Benzinga Evotec Expands Neuroscience Collaboration with Bristol Myers October 08, 2021 Bristol Myers Squibb & Co (NYSE: BMY) has expanded its neuroscience collaboration with Evotec SE (OTC: EVTCY) to include a new cell type. Related:... Via Benzinga Bristol Myers Exercises Option In-License Evotec's Neurodegenerative Candidate September 02, 2021 Evotec SE (OTC: EVTCY) says that Bristol Myers Squibb Co (NYSE: BMY) has exercised its option to enter into an exclusive global license for EVT8683. It... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
